Get Live Data

Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Latest Share Chat

  2. Share Prices
  3. Astrazeneca Share Price
  4. Astrazeneca Share News
  5. UK Earnings, Trading Statements Calendar - Week Ahead

Pin to quick picksAstrazeneca Share News (AZN)

Astrazeneca Information

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,392.00
Bid: 12,376.00
Ask: 12,380.00
Change: -74.00 (-0.59%)
Spread: 4.00 (0.032%)
Open: 12,466.00
High: 12,512.00
Low: 12,330.00
Prev. Close: 12,392.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK Earnings, Trading Statements Calendar - Week Ahead

Fri, 31st Oct 2014 16:18

UK Earnings, Trading Statements Calendar 
Monday, November 3 
HSBC HoldingsInterim Management Statement
Telecity GroupInterim Management Statement
Tuesday, November 4 
Advanced Computer Software GroupHalf Year Results
Associated British FoodsFull Year Results
Legal & General GroupInterim Management Statement
GlencoreInterim Management Statement
Weir GroupInterim Management Statement
Hilton Food GroupInterim Management Statement
Imperial Tobacco GroupFull Year Results
Jardine Lloyd Thompson GroupInterim Management Statement
PersimmonInterim Management Statement
Unite GroupInterim Management Statement
OneSavings BankInterim Management Statement
888 HoldingsTrading Update
Wednesday, November 5 
Lancashire HoldingsQ3 Results
First DerivativesHalf Year Results
Avocet MiningInterim Management Statement
MeggittInterim Management Statement
Marks & Spencer GroupHalf Year Results
FirstGroupHalf Year Results
Mithras Investment TrustInterim Management Statement
Old MutualInterim Management Statement
JD WetherspoonInterim Management Statement
WincantonInterim Management Statement
HuntingHalf Year Results
MarshallsInterim Management Statement
Drax GroupInterim Management Statement
esure GroupInterim Management Statement
AlentInterim Management Statement
Thursday, November 6 
Promethean WorldInterim Management Statement
Tate & LyleHalf Year Results
Shanks GroupHalf Year Results
Dairy CrestHalf Year Results
Coca-Cola HBC AGQ3 Results
AstraZenecaQ3 Results
STV GroupInterim Management Statement
Croda InternationalInterim Management Statement
DS SmithTrading statement
Costain GroupInterim Management Statement
Intu PropertieInterim Management Statement
ExperianHalf Year Results
BeazleyInterim Management Statement
Cable & Wireless CommunicationsHalf Year Results
Halfords GroupHalf Year Results
InmarsatQ3 Results
London MiningInterim Management Statement
Randgold ResourcesQ3 Results
RightmoveInterim Management Statement
RSA Insurance GroupInterim Management Statement
SchrodersInterim Management Statement
SynthomerInterim Management Statement
WM Morrison SupermarketsInterim Management Statement
Hikma PharmaceuticalsInterim Management Statement
CobhamInterim Management Statement
Stock Spirits GroupInterim Management Statement
SuperGroupTrading statement
Friday, November 7 
Croda InternationalInterim Management Statement
Scottish Mortgage Investment TrustHalf Year Results
Spirax-Sarco EngineeringHalf Year Results
Ark Therapeutics GroupInterim Management Statement
Capital & RegionalInterim Management Statement
Rentokil InitialTrading statement
Admiral GroupInterim Management Statement
National GridHalf Year Results
Capital & Counties PropertiesInterim Management Statement
Bovis Homes GroupInterim Management Statement
  
Copyright 2014 Alliance News Limited. All Rights Reserved.
  

More News
16 Oct 2023 08:34

TOP NEWS: AstraZeneca's cancer drug gets priority review from US FDA

(Alliance News) - AstraZeneca PLC on Monday said that its new drug application for Tagrisso has been granted priority review in the US, after trial results extended progression-free survival.

Read more
4 Oct 2023 12:14

IN BRIEF: AstraZeneca's Forxiga drug shows positive results in trial

AstraZeneca PLC - Cambridge-based pharmaceutical maker - Says Forxiga drug meets primary endpoints in T2NOW phase three trial and shows "clinically meaningful" improvements in the glycaemic control among type two diabetes patients between the ages of 10 and 17. Adds safety results in patient cohort were consistent with those in adults with type two diabetes.

Read more
3 Oct 2023 16:55

LONDON MARKET CLOSE: Stocks red as rate rise fears continue to grow

(Alliance News) - Stocks in London were lower at the close on Tuesday after unexpectedly strong US job openings data added to fears that interest rates in the world's largest economy will stay higher for longer.

Read more
3 Oct 2023 11:59

LONDON MARKET MIDDAY: HSBC and StanChart help FTSE 100 outperform

(Alliance News) - London's FTSE 100 grew in confidence as Tuesday morning progressed, going into the afternoon in the green and outperforming European peers.

Read more
3 Oct 2023 08:36

TOP NEWS: AstraZeneca settles Nexium and Prilosec litigation

(Alliance News) - AstraZeneca PLC on Tuesday said it has settled legal matters involving its Nexium acid reflux and Prilosec heartburn products, parting with USD425 million.

Read more
3 Oct 2023 07:41

LONDON BRIEFING: Greggs sales rise; boohoo cuts revenue outlook

(Alliance News) - London's FTSE 100 is set to fall further on Tuesday, after a sell-off at the start of the week, with hawkish words from a US central banker reinforcing the 'higher-for-longer' interest rates messaging.

Read more
3 Oct 2023 07:24

AstraZeneca agrees to settle most Nexium, Prilosec claims

(Sharecast News) - Global pharmaceutical company AstraZeneca has agreed to settle litigation on product liability related to two of its widely-used heartburn drugs, Nexium and Prilosec, it announced on Tuesday.

Read more
25 Sep 2023 09:13

LONDON BROKER RATINGS: Jefferies raises AstraZeneca to 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more
25 Sep 2023 07:43

LONDON BRIEFING: Stocks seen lower; Aviva buys AIG's UK protection arm

(Alliance News) - Stocks in London were set to open lower on Monday as investors eyed fresh concerns for the already fragile Chinese property sector.

Read more
22 Sep 2023 08:42

LONDON MARKET OPEN: Stocks slip after central bank rate calls

(Alliance News) - Stock prices in London opened lower on Friday, but managed to avoid the steep declines seen in New York, as investors mulled over an eventful week dominated by central bank decisions.

Read more
22 Sep 2023 08:13

TOP NEWS: AstraZeneca's datopotamab deruxtecan shows positive results

(Alliance News) - AstraZeneca PLC on Friday said phase three data showed that datopotamab deruxtecan delivered improvement in progression-free survival in breast cancer patients.

Read more
22 Sep 2023 07:27

AstraZeneca reports positive findings from breast cancer threatment trial

(Sharecast News) - New high-level results from AstraZeneca's TROPION-Breast01 phase three trial, released on Friday, carried encouraging news for patients with inoperable or metastatic hormone receptor (HR)-positive, HER2-low or negative breast cancer.

Read more
20 Sep 2023 08:44

TOP NEWS: AstraZeneca's rare disease business buys Pfizer portfolio

(Alliance News) - AstraZeneca PLC on Wednesday said rare disease business Alexion has signed a purchase and licence agreement for a rare disease programme portfolio from Pfizer Inc.

Read more
15 Sep 2023 15:27

AstraZeneca and Daiichi Sankyo's Enhertu recommended for approval

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd's Enhertu has been recommended for approval in the EU on Friday.

Read more
14 Sep 2023 08:25

Smith & Nephew brings BT Chief Financial Officer Simon Lowth to board

(Alliance News) - Smith & Nephew PLC on Thursday announced that BT Group PLC's chief financial officer, Simon Lowth, will join the board as independent non-executive director on January 1.

Read more
141516171819202122

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.